Cision PR Newswire

Accident Accident Air Pollution All News Annoucement Argriculture Art ASEAN Book

Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma

SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business segments. With the gradual realization of commercial launch and international expansion for its core products, the company is accelerating its transition from Biotech to Biopharma: CEVIRA®, the world's first...

Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering

Cision PR Newswire

Why Helsinki Should Be on Every Art Lover’s Travel List in Summer 2027

HELSINKI, Aug. 28, 2026 /PRNewswire/ -- Following a record-breaking edition that attracted more than half...

Cision PR Newswire

Lasfit Expands Its Vehicle-Specific Ford F-150 Upgrade Solutions Across Lighting, Protection and Outdoor Use

LOS ANGELES, Aug. 28, 2026 /PRNewswire/ -- Lasfit has rolled out brand-new LED ditch...

Cision PR Newswire

InxMed Announces Publication in The Lancet Oncology Featuring Encouraging Antitumor Activity of Ifebemtinib in Combination with Garsorasib in Previously Treated Metastatic Colorectal Cancer (CRC)...

NANJING, China, Aug. 28, 2026 /PRNewswire/ -- InxMed Co., Ltd ("InxMed"), a clinical-stage biotechnology...

Cision PR Newswire

DeriW: A Zero-Gas Trading Platform to Debut With Testnet at Consensus Hong Kong 2025

HONG...

Baltics leading pharmaceutical company Grindeks expands to new export markets worldwide

RIGA,...

NX Taiwan Becomes First Japanese Company to Receive QMS Certification for Medical Devices at Its NEXT3 Warehouse in Taoyuan City

TOKYO, Feb. 17, 2025 /PRNewswire/ -- Nippon Express (Taiwan) Co., Ltd. (hereafter "NX Taiwan"), a group company of NIPPON EXPRESS HOLDINGS, INC., obtained certification...

Cision PR Newswire

Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma

Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering

Why Helsinki Should Be on Every Art Lover’s Travel List in Summer 2027

Lasfit Expands Its Vehicle-Specific Ford F-150 Upgrade Solutions Across Lighting, Protection and Outdoor Use

InxMed Announces Publication in The Lancet Oncology Featuring Encouraging Antitumor Activity of Ifebemtinib in Combination with Garsorasib in Previously Treated Metastatic Colorectal Cancer (CRC)...

ABOUT US

FOLLOW US